Healthcare Information Services / Revenue Cycle Management
Strategic Profile
AI-driven solutions and strategic partnerships are strengthening TruBridge's differentiation, supporting market expansion and long-term growth in digital healthcare. Operational efficiencies via offshoring and rising demand for outsourced billing position TruBridge for sustained cost savings and recurring revenue streams.
Cyborg Score Rationale
TruBridge demonstrates solid fundamentals with strong recurring revenue (95% of Q2 2025 revenue), improved profitability, and strategic AI/digital investments. However, flat revenue growth, modest market cap of ~$290M, and mixed analyst sentiment temper upside potential.
Top Insights
Recurring revenue accounts for 95% of total revenue, providing revenue stability
Company showed significant improvement in profitability with GAAP net income of $2.6M vs prior net loss of $4.4M, and non-GAAP net income increased to $7.9M
Company rebranded from Computer Programs and Systems, Inc. to TruBridge in March 2024; founded in 1979
Analyst consensus rating is "Hold" with target price of $24.88
Named Competitors
EHR & Healthcare Analytics — Clinical data analytics and EHR solutions
Cloud-Based RCM — Revenue cycle management and patient engagement
Healthcare Services — Senior living and post-acute care services
Recent Developments
(Mar 2026) Quarterly earnings release scheduled for Monday following earnings call on Nov 7, 2025
(Aug 2025) Q2 2025 results showed flat revenue at $85.7M but improved profitability with adjusted EBITDA rising to $13.7M
(Aug 2025) Revised 2025 full-year guidance to $345-350M revenue while raising adjusted EBITDA guidance to $62-67M
(Jun 2025) CEO participated in Truist Securities Healthcare Disruptors & Digital Health Conference
Open the full interactive TruBridge, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.